Phone: 959-333-0983
Phone: 959-333-0983
$54.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
Selank is examined in research settings as a synthetic peptide analog derived from the endogenous tetrapeptide tuftsin. Research involving Selank focuses on peptide-mediated signaling, receptor interaction behavior, and regulatory neuropeptide pathways within controlled laboratory systems.
$54.99
Synthetic Regulatory Neuropeptide Analog
Selank is a synthetic peptide supplied exclusively for laboratory and analytical research purposes. This compound is studied in controlled research environments for its role in neuropeptide signaling research, peptide–receptor interaction models, and central nervous system pathway investigations.
Each batch of Selank is independently third-party tested to verify identity and purity, supporting accuracy and reproducibility in scientific research applications.
Selank is studied in laboratory and preclinical research environments to better understand how short regulatory peptides influence neuropeptide signaling pathways. Researchers examine this compound to explore:
As a modified peptide analog, Selank provides a controlled model for studying neuropeptide signaling mechanisms at the molecular level.
In experimental models, Selank is examined for its interaction with cellular signaling pathways involved in neuropeptide communication. Research focuses on signal modulation, receptor binding behavior, and pathway coordination under controlled laboratory conditions.
These investigations are mechanistic and exploratory and do not imply neurological, psychological, behavioral, or therapeutic outcomes.
Selank supplied by ResearchChemical.com is produced under controlled peptide synthesis conditions to support compound integrity, purity, and reproducibility.
Manufacturing and verification standards include:
These measures ensure transparency and reliability for laboratory research use.
Laboratory supplies and dilution solutions are not included.
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
Store Selank in a cool, dry environment away from direct light. Refrigerate after reconstitution, if applicable, to maintain peptide stability. Avoid repeated freeze-thaw cycles and follow standard laboratory handling protocols to prevent contamination or degradation.
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
Selank is:
The information provided on this page is for educational and informational purposes only and should not be interpreted as medical advice. ResearchChemical.com assumes no liability for misuse, improper handling, or use outside of controlled research environments. It is the purchaser’s responsibility to ensure compliance with all applicable laws and regulations.
Selank is a synthetic analogue of naturally occurring tuftsin, a peptide involved in immune responses. It is designed to be more stable and selank research indicates it has anxiolytic and immunomodulatory effects, often referred to as the “peptide anxiolytic selank”.
Selank’s mechanism of action is being studied to involve interacting with the cerebral catecholamine system, specifically by modulating the levels of monoamine neurotransmitters. It also affects GABA receptor agonists and opioid receptors, contributing to its pronounced anxiolytic effects which are currently under study.
Selank’s mechanism of action involves modulating the cerebral catecholamine system, but it does not directly increase dopamine levels. It influences monoamine neurotransmitters, including dopamine, but its primary effects are related to its anxiolytic and immunomodulatory properties. This includes its effects on emotional and stress reactions in the body which are all being vastly studied in new and upcoming laboratory research.
Selank’s anxiolytic effects are observed relatively quickly after administration, with temporary dynamics observed in clinical trials and laboratory research. Its rapid onset makes it a potential candidate for managing anxiety and stress reactions.
Selank is used in laboratory research as a peptide anxiolytic to manage anxiety and stress-related disorders, particularly generalized anxiety disorder and unpredictable chronic mild stress. Selank administration affects have been studied for cognitive processes, emotional reactions, and effects on the immune system in research experimentations.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
Selank is:
The information provided on this page is for educational and informational purposes only and should not be interpreted as medical advice. ResearchChemical.com assumes no liability for misuse, improper handling, or use outside of controlled research environments. It is the purchaser’s responsibility to ensure compliance with all applicable laws and regulations.
1. Peregud, D. I., Baronets, V. Y., Terebilina, N. N., & Gulyaeva, N. V. (2023). Role of BDNF in neuroplasticity associated with alcohol dependence. Biochemistry (Moscow), 88(3), 404-416.
2. Gudasheva, T. A. (2015). Theoretical grounds and technologies for dipeptide drug development. Russian Chemical Bulletin, 64(9), 2012-2021.
3. Kozlovskii, I. I., & Danchev, N. D. (2003). The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats. Neuroscience and Behavioral Physiology, 33, 639-643.
4. Zolotarev, Y. A., Kovalev, G. I., Kost, N. V., Voevodina, M. E., Sokolov, O. Y., Dadayan, A. K., … & Myasoedov, N. F. (2016). Anxiolytic activity of the neuroprotective peptide HLDF-6 and its effects on brain neurotransmitter systems in BALB/c and C57BL/6 mice. Journal of Psychopharmacology, 30(9), 922-935.
5. Povarov, I. S., Kondratenko, R. V., Derevyagin, V. I., Myasoedov, N. F., & Skrebitsky, V. G. (2017). Effect of selank on spontaneous synaptic activity of rat hippocampal CA1 neurons. Bulletin of experimental biology and medicine, 162(5), 640.
6. Filatova, E., Kasian, A., Kolomin, T., Rybalkina, E., Alieva, A., Andreeva, L., … & Shadrina, M. (2017). GABA, Selank, and olanzapine affect the expression of genes involved in GABAergic neurotransmission in IMR-32 Cells. Frontiers in Pharmacology, 8, 89.
7. Koroleva, S. V., & Mjasoedov, N. F. (2019). Physiological effects of Selank and its fragments. Biology Bulletin, 46(4), 407-414.
8. Samotrueva, M., Yasenyavskaya, A., Myasoedov, N., & Andreeva, L. RePResentAtIVes oF neURoPePtIDes—seLAnK AnD PRo-GLY-PRo-LeU As MoDULAtoRs oF IMMUnoReACtIVItY In ConDItIons oF” soCIAL” stRess. pharmacology, 3, 5.
9. Medvedev, V. E., Tereshchenko, O. N., AIu, I., Chobanu, I. K., Kost, N. V., & Miasoedov, N. F. (2014). A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova, 114(7), 17-22.
10. Slominsky, P. A., Shadrina, M. I., Kolomin, T. A., Stavrovskaya, A. V., Filatova, E. V., Andreeva, L. A., … & Myasoedov, N. F. (2017, May). Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. In Doklady Biological Sciences (Vol. 474, pp. 106-109). Pleiades Publishing.
11. Monica Shetty, K. P. L. (2017). Study of Anxiolytic Activity in Mice Using Vacha Churnam (Rasayana Preparation-Ayurvedic System of Medicine) (Doctoral dissertation, CL Baid Metha College of Pharmacy, Chennai).
12. Zolotarev, Y. A., Sokolov, O. Y., Kost, N. V., Vaskovsky, B. V., Myasoedov, N. F., & Zozulya, A. A. (2004). Leu-enkephalin generally labeled with tritium in studying the Selank inhibiting effect on the enkephalin-degrading enzymes of human blood plasma. Russian Journal of Bioorganic Chemistry, 30, 207-212.
13. Mikhailova, N. A., Voevodin, D. A., & Lazarev, S. A. (2020). A modern view of pro-/eukaryote interactions in the human body as the basis for development of next-generation probiotics. Journal of microbiology, epidemiology and immunobiology, 97(4), 346-355.
Please note that the above references provide evidence for the potential benefits of Selank Peptide as stated in the product description. For more in-depth information, kindly refer to these scholarly works.
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.